I smell Phase 3 trialsBased on the amount af money raised by the recent PP, the funds secured by the PP convertible debentures, and the offer of additional convertible debentures to share holders of record as of March 3, they have amassed an impressive warchest of funds. My gut is telling me the results are equal to or even better than they expected and they are just waiting on the algorithm to confirm the hard locked information. I am betting heavily they are gearing up for Phase 3 trials. This SP will hit between $3 and $7 per share during Phase 3 and will be bought out by a major player such as Pfizer. This is massive news. In my opinion only. Thanks-Buda.